Replicate Bioscience is a biotechnology company developing self-replicating RNA (srRNA) technologies to expand treatment options. Their srRNA vectors inside cells drive repeated production of natural RNA, enabling outsized protein expression and durable therapeutic effects. The company is pursuing a broad pipeline across infectious disease, oncology, and autoimmune disorders, aiming to improve efficacy over conventional linear RNA approaches. Based in the United States, Replicate emphasizes RNA-based therapies with potential for wide-ranging immune and therapeutic applications.
No recent news for this company.
No recent deals for this company.